Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Balance Sheets

v3.25.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 29, 2025
Mar. 30, 2024
Current assets    
Cash and cash equivalents $ 429,382 $ 656,376
Accounts receivable, less allowance for doubtful accounts of: March 2025 - $31,853; March 2024 - $26,369 1,321,663 1,263,329
Inventories 1,627,025 1,697,823
Other current assets 408,028 493,194
Current assets of discontinued operations 0 116,225
Total current assets 3,786,098 4,226,947
Property, plant and equipment, net 720,879 788,992
Intangible assets, net 1,710,707 1,776,482
Goodwill 603,386 645,356
Operating lease right-of-use assets 1,262,319 1,255,074
Other assets 1,294,147 1,210,470
Other assets of discontinued operations 0 1,709,642
TOTAL ASSETS 9,377,536 11,612,963
Current liabilities    
Short-term borrowings 11,916 263,938
Current portion of long-term debt 540,579 1,000,721
Accounts payable 789,570 788,477
Accrued liabilities 1,355,788 1,323,982
Current liabilities of discontinued operations 0 79,861
Total current liabilities 2,697,853 3,456,979
Long-term debt 3,425,650 4,702,284
Operating lease liabilities 1,079,182 1,087,304
Other liabilities 687,492 636,090
Other liabilities of discontinued operations 0 71,941
Total liabilities 7,890,177 9,954,598
Commitments and contingencies
Stockholders' equity    
Preferred Stock, par value $1; shares authorized, 25,000,000; no shares outstanding at March 2025 or March 2024 0 0
Common Stock, stated value $0.25; shares authorized, 1,200,000,000; shares outstanding at March 2025 - 389,695,199; March 2024 - 388,836,219 97,424 97,209
Additional paid-in capital 3,540,686 3,600,071
Accumulated other comprehensive loss (977,740) (1,064,331)
Accumulated deficit (1,173,011) (974,584)
Total stockholders’ equity 1,487,359 1,658,365
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 9,377,536 $ 11,612,963